InvestorsHub Logo
Replies to #4 on CohBar Inc (CWBR)

MinnieM

10/07/17 4:10 PM

#5 RE: codaras #4

Mitochondria based therapeutics (MBTs) are the rage these days. Many scientists/companies are doing research in this arena. That's why I wasn't in a hurry to do the research for a couple more weeks. I don't feel in a hurry since I thought the price was too high for where they are now. Apparently, others feel differently. It would have been a great flip from the day I created this board.

Here's a google search on mitochondria based therapeutics. https://www.google.com/search?q=mitochondria+based+therapeutics&rlz=1C1EODB_enUS533US533&oq=mitochondria+based+therapeutics&aqs=chrome..69i57j0.12632j0j8&sourceid=chrome&ie=UTF-8

You'll find a lot of work listed on pubmed also.
https://www.ncbi.nlm.nih.gov/pubmed/?term=mitochondria+based+therapeutics

https://www.ncbi.nlm.nih.gov/pubmed/?term=mitochondria+genome

https://www.ncbi.nlm.nih.gov/pubmed/?term=mitochondria+peptides

I'm hoping to find their preclinical data. From the prospectus dated Oct 5, 2017: https://www.sec.gov/Archives/edgar/data/1522602/000121390017010315/f424b3100517_cohbarinc.htm

All of our pipeline MDPs and MBT candidates are in the pre-clinical stage of development



We are looking at this very early since there hasn't been a ph1 safety trial yet on any of their drug candidates. Was a trial start date mentioned in the call? Has an IND been submitted to the FDA?

It will be interesting to follow their progress. All of these companies targeting anti-aging and healthspan are of great interest to me. It seems that diabetes and alzheimer's are common targets for them.















Regis999

10/09/17 7:54 PM

#9 RE: codaras #4

Nice job Codaras !! Ready for an elevator pitch?